{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T04:39:41Z","timestamp":1763095181457,"version":"3.45.0"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"20","funder":[{"DOI":"10.13039\/501100003593","name":"CNPq,","doi-asserted-by":"publisher","award":["3093\/2021\/9"],"award-info":[{"award-number":["3093\/2021\/9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"INCTCat\u00e1lise\/FAPESC\/CNPq\/CAPES","doi-asserted-by":"publisher","award":["2019TR0847"],"award-info":[{"award-number":["2019TR0847"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objective:<\/jats:title>\n                    <jats:p>Cancer is a global health burden. Despite advances in early detection and\ntherapeutics, cancer prevalence continues to increase, underscoring the need for innovative therapeutic strategies.\nDysregulation of cell death mechanisms is a hallmark of cancer that can lead to apoptosis evasion, which strongly\ncontributes to tumor progression and therapy resistance. Isothiouronium salts have attracted attention as promising\nantitumor agents. This study aimed to evaluate the in vitro antitumor effect of an isothiouronium salt (ISMF08)\non the B16F10 melanoma cell line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The antitumor properties of IS-MF08 were investigated by incubating B16F10 cells with the compound\nat different concentrations. Cytotoxicity was determined by the (3-(4,5-dimethylthiazol-2-yl)-2,5-\ndiphenyltetrazolium bromide) (MTT) assay, cell cycle arrest and cell death mechanisms by flow cytometry, and\nmorphological alterations by transmission electron microscopy. Physicochemical parameters related to druglikeness\nwere predicted in silico using the SwissADME tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>IS-MF08 was cytotoxic to melanoma cells, triggering cell cycle arrest and disrupting mitosis. The mechanism\nof cell death was compatible with apoptosis, as indicated by annexin V-FITC experiments and the relevant\nmorphological changes in cell structure observed by transmission electron microscopy. SwissADME predicted\nthat IS-MF08 has good physicochemical properties related to absorption and permeation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The numerous mechanisms of cell death triggered by IS-MF08 and its drug-likeness make it an\ninteresting molecule in the search for new antitumor compounds, contributing to therapies targeting the dysregulation\nof cellular mechanisms such as apoptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715206358941250413154017","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T07:14:06Z","timestamp":1745565246000},"page":"1597-1606","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methyl (Z)-2-(Isothioureidomethyl)-2-pentenoate Hydrobromide Induces Cell Cycle Arrest and Disrupts Mitosis in a Melanoma Cell Line"],"prefix":"10.2174","volume":"25","author":[{"given":"Laura","family":"Sartori Assuncao","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"},{"name":"Graduate Program in Pharmacy, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iara Patricia","family":"Kretzer","sequence":"additional","affiliation":[{"name":"Department of Clinical Analysis, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelver Alexander","family":"Sierra Restrepo","sequence":"additional","affiliation":[{"name":"Graduate Program in Material Engineering, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas Joao","family":"de Mello Junior","sequence":"additional","affiliation":[{"name":"Graduate Program in Biochemistry, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio Augusto","family":"Rocha Barbosa","sequence":"additional","affiliation":[{"name":"Polydoro Ernani de S\u00e3o Thiago University Hospital, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misael","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-1624","authenticated-orcid":true,"given":"Marcus","family":"Mandolesi Sa","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-2948","authenticated-orcid":true,"given":"Tania Beatriz","family":"Creczynski-Pasa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florian\u00f3polis, SC 88040-900, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"Kocarnik J.M.","year":"2022","unstructured":"Kocarnik J.M.; Compton K.; Dean F.E.; Fu W.; Gaw B.L.; Harvey J.D.; Henrikson H.J.; Lu D.; Pennini A.; Xu R.; Ababneh E.; Abbasi-Kangevari M.; Abbastabar H.; Abd-Elsalam S.M.; Abdoli A.; Abedi A.; Abidi H.; Abolhassani H.; Adedeji I.A.; Adnani Q.E.S.; Advani S.M.; Afzal M.S.; Aghaali M.; Ahinkorah B.O.; Ahmad S.; Ahmad T.; Ahmadi A.; Ahmadi S.; Ahmed R.T.; Ahmed S.Y.; Akalu G.T.; Aklilu A.; Akram T.; Akunna C.J.; Al Hamad H.; Alahdab F.; Al-Aly Z.; Ali S.; Alimohamadi Y.; Alipour V.; Aljunid S.M.; Alkhayyat M.; Almasi-Hashiani A.; Almasri N.A.; Al-Maweri S.A.A.; Almustanyir S.; Alonso N.; Alvis-Guzman N.; Amu H.; Anbesu E.W.; Ancuceanu R.; Ansari F.; Ansari-Moghaddam A.; Antwi M.H.; Anvari D.; Anyasodor A.E.; Aqeel M.; Arabloo J.; Arab-Zozani M.; Aremu O.; Ariffin H.; Aripov T.; Arshad M.; Artaman A.; Arulappan J.; Asemi Z.; Asghari Jafarabadi M.; Ashraf T.; Atorkey P.; Aujayeb A.; Ausloos M.; Awedew A.F.; Ayala Quintanilla B.P.; Ayenew T.; Azab M.A.; Azadnajafabad S.; Azari Jafari A.; Azarian G.; Azzam A.Y.; Badiye A.D.; Bahadory S.; Baig A.A.; Baker J.L.; Balakrishnan S.; Banach M.; B&#xE4;rnighausen T.W.; Barone-Adesi F.; Barra F.; Barrow A.; Behzadifar M.; Belgaumi U.I.; Bezabhe W.M.M.; Bezabih Y.M.; Bhagat D.S.; Bhagavathula A.S.; Bhardwaj N.; Bhardwaj P.; Bhaskar S.; Bhattacharyya K.; Bhojaraja V.S.; Bibi S.; Bijani A.; Biondi A.; Bisignano C.; Bj&#xF8;rge T.; Bleyer A.; Blyuss O.; Bolarinwa O.A.; Bolla S.R.; Braithwaite D.; Brar A.; Brenner H.; Bustamante-Teixeira M.T.; Butt N.S.; Butt Z.A.; Caetano dos Santos F.L.; Cao Y.; Carreras G.; Catal&#xE1;-L&#xF3;pez F.; Cembranel F.; Cerin E.; Cernigliaro A.; Chakinala R.C.; Chattu S.K.; Chattu V.K.; Chaturvedi P.; Chimed-Ochir O.; Cho D.Y.; Christopher D.J.; Chu D.T.; Chung M.T.; Conde J.; Cort&#xE9;s S.; Cortesi P.A.; Costa V.M.; Cunha A.R.; Dadras O.; Dagnew A.B.; Dahlawi S.M.A.; Dai X.; Dandona L.; Dandona R.; Darwesh A.M.; das Neves, J.; De la Hoz, F.P.; Demis, A.B.; Denova-Guti&#xE9;rrez, E.; Dhamnetiya, D.; Dhimal, M.L.; Dhimal, M.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Do, H.P.; Doaei, S.; Dorostkar, F.; dos Santos Figueiredo, F.W.; Driscoll, T.R.; Ebrahimi, H.; Eftekharzadeh, S.; El Tantawi, M.; El-Abid, H.; Elbarazi, I.; Elhabashy, H.R.; Elhadi, M.; El-Jaafary, S.I.; Eshrati, B.; Eskandarieh, S.; Esmaeilzadeh, F.; Etemadi, A.; Ezzikouri, S.; Faisaluddin, M.; Faraon, E.J.A.; Fares, J.; Farzadfar, F.; Feroze, A.H.; Ferrero, S.; Ferro Desideri, L.; Filip, I.; Fischer, F.; Fisher, J.L.; Foroutan, M.; Fukumoto, T.; Gaal, P.A.; Gad, M.M.; Gadanya, M.A.; Gallus, S.; Gaspar Fonseca, M.; Getachew Obsa, A.; Ghafourifard, M.; Ghashghaee, A.; Ghith, N.; Gholamalizadeh, M.; Gilani, S.A.; Ginindza, T.G.; Gizaw, A.T.T.; Glasbey, J.C.; Golechha, M.; Goleij, P.; Gomez, R.S.; Gopalani, S.V.; Gorini, G.; Goudarzi, H.; Grosso, G.; Gubari, M.I.M.; Guerra, M.R.; Guha, A.; Gunasekera, D.S.; Gupta, B.; Gupta, V.B.; Gupta, V.K.; Guti&#xE9;rrez, R.A.; Hafezi-Nejad, N.; Haider, M.R.; Haj-Mirzaian, A.; Halwani, R.; Hamadeh, R.R.; Hameed, S.; Hamidi, S.; Hanif, A.; Haque, S.; Harlianto, N.I.; Haro, J.M.; Hasaballah, A.I.; Hassanipour, S.; Hay, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Heidari, M.; Herrera-Serna, B.Y.; Herteliu, C.; Hezam, K.; Holla, R.; Hossain, M.M.; Hossain, M.B.H.; Hosseini, M.S.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Hsairi, M.; Huang, J.; Hugo, F.N.; Hussain, R.; Hussein, N.R.; Hwang, B.F.; Iavicoli, I.; Ibitoye, S.E.; Ida, F.; Ikuta, K.S.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Irham, L.M.; Islam, J.Y.; Islam, R.M.; Islam, S.M.S.; Ismail, N.E.; Isola, G.; Iwagami, M.; Jacob, L.; Jain, V.; Jakovljevic, M.B.; Javaheri, T.; Jayaram, S.; Jazayeri, S.B.; Jha, R.P.; Jonas, J.B.; Joo, T.; Joseph, N.; Joukar, F.; J&#xFC;risson, M.; Kabir, A.; Kahrizi, D.; Kalankesh, L.R.; Kalhor, R.; Kaliyadan, F.; Kalkonde, Y.; Kamath, A.; Kameran Al-Salihi, N.; Kandel, H.; Kapoor, N.; Karch, A.; Kasa, A.S.; Katikireddi, S.V.; Kauppila, J.H.; Kavetskyy, T.; Kebede, S.A.; Keshavarz, P.; Keykhaei, M.; Khader, Y.S.; Khalilov, R.; Khan, G.; Khan, M.; Khan, M.N.; Khan, M.A.B.; Khang, Y.H.; Khater, A.M.; Khayamzadeh, M.; Kim, G.R.; Kim, Y.J.; Kisa, A.; Kisa, S.; Kissimova-Skarbek, K.; Kopec, J.A.; Koteeswaran, R.; Koul, P.A.; Koulmane, L.S.L.; Koyanagi, A.; Kucuk Bicer, B.; Kugbey, N.; Kumar, G.A.; Kumar, N.; Kumar, N.; Kurmi, O.P.; Kutluk, T.; La Vecchia, C.; Lami, F.H.; Landires, I.; Lauriola, P.; Lee, S.; Lee, S.W.H.; Lee, W.C.; Lee, Y.H.; Leigh, J.; Leong, E.; Li, J.; Li, M.C.; Liu, X.; Loureiro, J.A.; Lunevicius, R.; Magdy Abd El Razek, M.; Majeed, A.; Makki, A.; Male, S.; Malik, A.A.; Mansournia, M.A.; Martini, S.; Masoumi, S.Z.; Mathur, P.; McKee, M.; Mehrotra, R.; Mendoza, W.; Menezes, R.G.; Mengesha, E.W.; Mesregah, M.K.; Mestrovic, T.; Miao, J.J.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirzaei, H.; Mirzaei, H.R.; Misra, S.; Mithra, P.; Moghadaszadeh, M.; Mohammad, K.A.; Mohammad, Y.; Mohammadi, M.; Mohammadi, S.M.; Mohammadian-Hafshejani, A.; Mohammed, S.; Moka, N.; Mokdad, A.H.; Molokhia, M.; Monasta, L.; Moni, M.A.; Moosavi, M.A.; Moradi, Y.; Moraga, P.; Morgado-da-Costa, J.; Morrison, S.D.; Mosapour, A.; Mubarik, S.; Mwanri, L.; Nagarajan, A.J.; Nagaraju, S.P.; Nagata, C.; Naimzada, M.D.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Ndejjo, R.; Nduaguba, S.O.; Negoi, I.; Negru, S.M.; Neupane Kandel, S.; Nguyen, C.T.; Nguyen, H.L.T.; Niazi, R.K.; Nnaji, C.A.; Noor, N.M.; Nu&#xF1;ez-Samudio, V.; Nzoputam, C.I.; Oancea, B.; Ochir, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Olakunde, B.O.; Omar, E.; Omar Bali, A.; Omonisi, A.E.E.; Ong, S.; Onwujekwe, O.E.; Orru, H.; Ortega-Altamirano, D.V.; Otstavnov, N.; Otstavnov, S.S.; Owolabi, M.O.; P A, M.; Padubidri, J.R.; Pakshir, K.; Pana, A.; Panagiotakos, D.; Panda-Jonas, S.; Pardhan, S.; Park, E.C.; Park, E.K.; Pashazadeh Kan, F.; Patel, H.K.; Patel, J.R.; Pati, S.; Pattanshetty, S.M.; Paudel, U.; Pereira, D.M.; Pereira, R.B.; Perianayagam, A.; Pillay, J.D.; Pirouzpanah, S.; Pishgar, F.; Podder, I.; Postma, M.J.; Pourjafar, H.; Prashant, A.; Preotescu, L.; Rabiee, M.; Rabiee, N.; Radfar, A.; Radhakrishnan, R.A.; Radhakrishnan, V.; Rafiee, A.; Rahim, F.; Rahimzadeh, S.; Rahman, M.; Rahman, M.A.; Rahmani, A.M.; Rajai, N.; Rajesh, A.; Rakovac, I.; Ram, P.; Ramezanzadeh, K.; Ranabhat, K.; Ranasinghe, P.; Rao, C.R.; Rao, S.J.; Rawassizadeh, R.; Razeghinia, M.S.; Renzaho, A.M.N.; Rezaei, N.; Rezaei, N.; Rezapour, A.; Roberts, T.J.; Rodriguez, J.A.B.; Rohloff, P.; Romoli, M.; Ronfani, L.; Roshandel, G.; Rwegerera, G.M.; S, M.; Sabour, S.; Saddik, B.; Saeed, U.; Sahebkar, A.; Sahoo, H.; Salehi, S.; Salem, M.R.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Sanabria, J.; Sankararaman, S.; Santric-Milicevic, M.M.; Sardiwalla, Y.; Sarveazad, A.; Sathian, B.; Sawhney, M.; Saylan, M.; Schneider, I.J.C.; Sekerija, M.; Seylani, A.; Shafaat, O.; Shaghaghi, Z.; Shaikh, M.A.; Shamsoddin, E.; Shannawaz, M.; Sharma, R.; Sheikh, A.; Sheikhbahaei, S.; Shetty, A.; Shetty, J.K.; Shetty, P.H.; Shibuya, K.; Shirkoohi, R.; Shivakumar, K.M.; Shivarov, V.; Siabani, S.; Siddappa Malleshappa, S.K.; Silva, D.A.S.; Singh, J.A.; Sintayehu, Y.; Skryabin, V.Y.; Skryabina, A.A.; Soeberg, M.J.; Sofi-Mahmudi, A.; Sotoudeh, H.; Steiropoulos, P.; Straif, K.; Subedi, R.; Sufiyan, M.B.; Sultan, I.; Sultana, S.; Sur, D.; Szerencs&#xE9;s, V.; Sz&#xF3;cska, M.; Tabar&#xE9;s-Seisdedos, R.; Tabuchi, T.; Tadbiri, H.; Taherkhani, A.; Takahashi, K.; Talaat, I.M.; Tan, K.K.; Tat, V.Y.; Tedla, B.A.A.; Tefera, Y.G.; Tehrani-Banihashemi, A.; Temsah, M.H.; Tesfay, F.H.; Tessema, G.A.; Thapar, R.; Thavamani, A.; Thoguluva, C.V.; Thomas, N.; Tohidinik, H.R.; Touvier, M.; Tovani-Palone, M.R.; Traini, E.; Tran, B.X.; Tran, K.B.; Tran, M.T.N.; Tripathy, J.P.; Tusa, B.S.; Ullah, I.; Ullah, S.; Umapathi, K.K.; Unnikrishnan, B.; Upadhyay, E.; Vacante, M.; Vaezi, M.; Valadan, T.S.; Velazquez, D.Z.; Veroux, M.; Violante, F.S.; Vlassov, V.; Vo, B.; Volovici, V.; Vu, G.T.; Waheed, Y.; Wamai, R.G.; Ward, P.; Wen, Y.F.; Westerman, R.; Winkler, A.S.; Yadav, L.; Yahyazadeh, J.S.H.; Yang, L.; Yaya, S.; Yazie, T.S.Y.; Yeshaw, Y.; Yonemoto, N.; Younis, M.Z.; Yousefi, Z.; Yu, C.; Yuce, D.; Yunusa, I.; Zadnik, V.; Zare, F.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, J.; Zhong, C.; Zhou, L.; Zhu, C.; Ziapour, A.; Zimmermann, I.R.; Fitzmaurice, C.; Murray, C.J.L.; Force, L.M. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019. JAMA Oncol  2022,8(3),420-444","journal-title":"JAMA Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F.","year":"2024","unstructured":"Bray F.; Laversanne M.; Sung H.; Ferlay J.; Siegel R.L.; Soerjomataram I.; Jemal A.; Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2024,74(3),229-263","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"Siegel R.L.","year":"2025","unstructured":"Siegel R.L.; Kratzer T.B.; Giaquinto A.N.; Sung H.; Jemal A.; Cancer statistics, 2025. CA Cancer J Clin  2025,75(1),10-45","journal-title":"CA Cancer J Clin"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21877","volume":"75","author":"Corn B.W.","year":"2025","unstructured":"Corn B.W.; Feldman D.B.; Cancer statistics, 2025: A hinge moment for optimism to morph into hope? CA Cancer J Clin  2025,75(1),7-9","journal-title":"CA Cancer J Clin"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.3390\/cancers16244219","volume":"16","author":"Prka&#x10D;in I.","year":"2024","unstructured":"Prka&#x10D;in I.; Mokos M.; Ferara N.; \u0160itum M.; Melanoma\u2019s new frontier: Exploring the latest advances in blood-based biomarkers for melanoma. Cancers (Basel)  2024,16(24),4219","journal-title":"Cancers (Basel)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","volume":"100","author":"Carr S.","year":"2020","unstructured":"Carr S.; Smith C.; Wernberg J.; Epidemiology and risk factors of melanoma. Surg Clin North Am  2020,100(1),1-12","journal-title":"Surg Clin North Am"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1158\/1078-0432.CCR-20-4092","volume":"27","author":"Atkins M.B.","year":"2021","unstructured":"Atkins M.B.; Curiel-Lewandrowski C.; Fisher D.E.; Swetter S.M.; Tsao H.; Aguirre-Ghiso J.A.; Soengas M.S.; Weeraratna A.T.; Flaherty K.T.; Herlyn M.; Sosman J.A.; Tawbi H.A.; Pavlick A.C.; Cassidy P.B.; Chandra S.; Chapman P.B.; Daud A.; Eroglu Z.; Ferris L.K.; Fox B.A.; Gershenwald J.E.; Gibney G.T.; Grossman D.; Hanks B.A.; Hanniford D.; Hernando E.; Jeter J.M.; Johnson D.B.; Khleif S.N.; Kirkwood J.M.; Leachman S.A.; Mays D.; Nelson K.C.; Sondak V.K.; Sullivan R.J.; Merlino G.; The State of Melanoma: Emergent challenges and opportunities. Clin Cancer Res  2021,27(10),2678-2697","journal-title":"Clin Cancer Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"Long G.V.","year":"2023","unstructured":"Long G.V.; Swetter S.M.; Menzies A.M.; Gershenwald J.E.; Scolyer R.A.; Cutaneous melanoma. Lancet  2023,402(10400),485-502","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"Domingues B.","year":"2018","unstructured":"Domingues B.; Lopes J.; Soares P.; P&#xF3;pulo H.; Melanoma treatment in review. ImmunoTargets Ther  2018,7,35-49","journal-title":"ImmunoTargets Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s43018-021-00192-x","volume":"2","year":"2021","unstructured":"Advancing cancer therapy. Nat Can  2021,2(3),245-246","journal-title":"Nat Can"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","volume":"22","author":"Soengas M.S.","year":"2003","unstructured":"Soengas M.S.; Lowe S.W.; Apoptosis and melanoma chemoresistance. Oncogene  2003,22(20),3138-3151","journal-title":"Oncogene"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: A review of programmed cell death. Toxicol Pathol  2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1582-4934.2009.00748.x","volume":"13","author":"Fulda S.","year":"2009","unstructured":"Fulda S.; Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med  2009,13(7),1221-1227","journal-title":"J Cell Mol Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.3390\/molecules29225412","volume":"29","author":"Chen P.","year":"2024","unstructured":"Chen P.; Ji X.Y.; Feng J.T.; Wang X.Q.; Zhang B.; The synergistic mechanism of Chelidonium majus alkaloids on melanoma treatment via a multi-strategy insight. Molecules  2024,29(22),5412","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.3390\/cancers13174363","volume":"13","author":"Neophytou C.M.","year":"2021","unstructured":"Neophytou C.M.; Trougakos I.P.; Erin N.; Papageorgis P.; Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers (Basel)  2021,13(17),4363","journal-title":"Cancers (Basel)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: The next generation. Cell  2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e41355","DOI":"10.1016\/j.heliyon.2024.e41355","volume":"11","author":"Koolivand Z.","year":"2025","unstructured":"Koolivand Z.; Bahreini F.; Rayzan E.; Rezaei N.; Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations. Heliyon  2025,11(1),e41355","journal-title":"Heliyon"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/cncr.23284","volume":"112","author":"Tarhini A.A.","year":"2008","unstructured":"Tarhini A.A.; Kirkwood J.M.; Tawbi H.; Gooding W.E.; Islam M.F.; Agarwala S.S.; Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma. Cancer  2008,112(5),1131-1138","journal-title":"Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.15171\/apb.2019.024","volume":"9","author":"Jan R.","year":"2019","unstructured":"Jan R.; Chaudhry G.S.; Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Adv Pharm Bull  2019,9(2),205-218","journal-title":"Adv Pharm Bull"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI34359","volume":"118","author":"Ashkenazi A.","year":"2008","unstructured":"Ashkenazi A.; Herbst R.S.; To kill a tumor cell: The potential of proapoptotic receptor agonists. J Clin Invest  2008,118(6),1979-1990","journal-title":"J Clin Invest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2014.05.002","volume":"31","author":"Fulda S.","year":"2015","unstructured":"Fulda S.; Targeting apoptosis for anticancer therapy. Semin Cancer Biol  2015,31,84-88","journal-title":"Semin Cancer Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1186\/s12967-024-05920-2","volume":"22","author":"Yu C.T.R.","year":"2024","unstructured":"Yu C.T.R.; Liao Y.T.A.; Chiang C.Y.N.; Chen J.M.M.; Pan H.Y.B.; Pan C.Y.; Jiang W.J.; Tsai J.R.; Yang T.Y.; Teng C.L.J.; Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum\/Golgi stress and apoptosis. J Transl Med  2024,22(1),1095","journal-title":"J Transl Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/ardp.19863190513","volume":"319","author":"Bella M.D.","year":"1986","unstructured":"Bella M.D.; Tait A.; Parenti C.; Bondi M.; Quaglio G.; S-aryl(tetramethyl)isothiouronium salts as possible antimicrobial agents, I. Arch Pharm (Weinheim)  1986,319(5),451-456","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/157018007780867870","volume":"4","author":"Venkatachalam T.","year":"2007","unstructured":"Venkatachalam T.; Vassilev A.; Benyunov A.; Grigoriants O.; Tibbles H.; Uckun F.; Stereochemistry as a determinant of the anti-leukemic potency of halopyridyl and thiazolyl thiourea compounds. Lett Drug Des Discov  2007,4(5),318-326","journal-title":"Lett Drug Des Discov"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/ph6050634","volume":"6","author":"El-Henawy A.","year":"2013","unstructured":"El-Henawy A.; Khowdiary M.; Badawi A.; Soliman H.; In vivo anti-leukemia, quantum chemical calculations and ADMET investigations of some quaternary and isothiouronium surfactants. Pharmaceuticals (Basel)  2013,6(5),634-649","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejmech.2013.10.017","volume":"70","author":"Ferreira M.","year":"2013","unstructured":"Ferreira M.; Assun&#xE7;&#xE3;o L.S.; Filippin-Monteiro F.B.; Creczynski-Pasa T.B.; S&#xE1; M.M.; Synthesis of 1,3-thiazine-2,4-diones with potential anticancer activity. Eur J Med Chem  2013,70,411-418","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1871520614666141130125148","volume":"15","author":"Cisilotto J.","year":"2015","unstructured":"Cisilotto J.; Ferreira M.; Filippin-Monteiro F.B.; Bortoluzzi A.J.; Sa M.M.; Creczynski-Pasa T.B.; Isothiouronium salts reduce NRAS expression, induce apoptosis and decrease invasion of melanoma cells. Anticancer Agents Med Chem  2015,15(3),353-362","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12951-016-0208-7","volume":"14","author":"Cohen S.","year":"2016","unstructured":"Cohen S.; Gelber C.; Natan M.; Banin E.; Corem-Salkmon E.; Margel S.; Synthesis and characterization of crosslinked polyisothiouronium methylstyrene nanoparticles of narrow size distribution for antibacterial and antibiofilm applications. J Nanobiotechnology  2016,14(1),56","journal-title":"J Nanobiotechnology"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/md21040218","volume":"21","author":"Wang D.P.","year":"2023","unstructured":"Wang D.P.; Wu L.H.; Li R.; He N.; Zhang Q.Y.; Zhao C.Y.; Jiang T.; A novel aldisine derivative exhibits potential antitumor effects by targeting JAK\/STAT3 signaling. Mar Drugs  2023,21(4),218","journal-title":"Mar Drugs"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejmech.2017.02.013","volume":"129","author":"Ferreira M.","year":"2017","unstructured":"Ferreira M.; Assun&#xE7;&#xE3;o L.S.; Silva A.H.; Filippin-Monteiro F.B.; Creczynski-Pasa T.B.; S&#xE1; M.M.; Allylic isothiouronium salts: The discovery of a novel class of thiourea analogues with antitumor activity. Eur J Med Chem  2017,129,151-158","journal-title":"Eur J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1359-6446(03)02828-9","volume":"8","author":"Yu H.","year":"2003","unstructured":"Yu H.; Adedoyin A.; ADME\u2013Tox in drug discovery: Integration of experimental and computational technologies. Drug Discov Today  2003,8(18),852-861","journal-title":"Drug Discov Today"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/15680266113139990033","volume":"13","author":"Cheng F.","year":"2013","unstructured":"Cheng F.; Li W.; Liu G.; Tang Y.; In silico ADMET prediction: Recent advances, current challenges and future trends. Curr Top Med Chem  2013,13(11),1273-1289","journal-title":"Curr Top Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"van de Waterbeemd H.","year":"2003","unstructured":"van de Waterbeemd H.; Gifford E.; ADMET in silico modelling: Towards prediction paradise? Nat Rev Drug Discov  2003,2(3),192-204","journal-title":"Nat Rev Drug Discov"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"110304","DOI":"10.1016\/j.abb.2025.110304","volume":"765","author":"Zaman H.","year":"2025","unstructured":"Zaman H.; Saeed A.; Ismail H.; Rashid M.; Unveiling the cyclopropyl appended acyl thiourea derivatives as antimicrobial,\u03b1-amylase and proteinase K inhibitors: Design, synthesis, biological evaluation, molecular docking, DFT and ADMET studies. Arch Biochem Biophys  2025,765,110304","journal-title":"Arch Biochem Biophys"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/00498254.2023.2245049","volume":"54","author":"Ekins S.","year":"2024","unstructured":"Ekins S.; Lane T.R.; Urbina F.; Puhl A.C.; In silico ADME\/tox comes of age: Twenty years later. Xenobiotica  2024,54(7),352-358","journal-title":"Xenobiotica"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/17460441.2020.1798926","volume":"15","author":"Kar S.","year":"2020","unstructured":"Kar S.; Leszczynski J.; Open access in silico tools to predict the ADMET profiling of drug candidates. Expert Opin Drug Discov  2020,15(12),1473-1487","journal-title":"Expert Opin Drug Discov"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"Ferreira L.L.G.","year":"2019","unstructured":"Ferreira L.L.G.; Andricopulo A.D.; ADMET modeling approaches in drug discovery. Drug Discov Today  2019,24(5),1157-1165","journal-title":"Drug Discov Today"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.4155\/fmc-2020-0259","volume":"12","author":"C&#xE1;ceres E.L.","year":"2020","unstructured":"C&#xE1;ceres E.L.; Tudor M.; Cheng A.C.; Deep learning approaches in predicting ADMET properties. Future Med Chem  2020,12(22),1995-1999","journal-title":"Future Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"14047","DOI":"10.1021\/acs.jmedchem.3c01083","volume":"66","author":"Beckers M.","year":"2023","unstructured":"Beckers M.; Sturm N.; Sirockin F.; Fechner N.; Stiefl N.; Prediction of small-molecule developability using large-scale in silico ADMET models. J Med Chem  2023,66(20),14047-14060","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12859-024-05861-z","volume":"25","author":"Aksamit N.","year":"2024","unstructured":"Aksamit N.; Tchagang A.; Li Y.; Ombuki-Berman B.; Hybrid fragment-SMILES tokenization for ADMET prediction in drug discovery. BMC Bioinformatics  2024,25(1),255","journal-title":"BMC Bioinformatics"},{"key":"ref=42","first-page":"1","author":"Freshney R.I.","year":"1987","unstructured":"Freshney R.I.;  Culture of Animal Cells: A manual of basic techniques  1987,1-4","journal-title":"Culture of Animal Cells: A manual of basic techniques"},{"key":"ref=43","first-page":"1","author":"Capes-Davis A.","year":"2021","unstructured":"Capes-Davis A.; Freshney R.I.;  Freshney\u2019s Culture of animal cells: A manual of basic technique and specialized applications  2021,1-6","journal-title":"Freshney\u2019s Culture of animal cells: A manual of basic technique and specialized applications"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3998\/ark.5550190.0011.b24","volume":"2010","author":"S&#xE1; M.M.","year":"2010","unstructured":"S&#xE1; M.M.; Ferreira M.; Bortoluzzi A.J.; Fernandes L.; Cunha S.; Exploring the reaction of multifunctional allylic bromides with N,S-dinucleophiles: Isothiouronium salts and analogs as useful motifs to assemble the 1,3-thiazine core. ARKIVOC  2010,2010(11),303-321","journal-title":"ARKIVOC"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth  1983,65(1-2),55-63","journal-title":"J Immunol Meth"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medicines11010003","volume":"11","author":"Das S.","year":"2024","unstructured":"Das S.; Roayapalley P.K.; Sakagami H.; Umemura N.; Gorecki D.K.J.; Hossain M.; Kawase M.; Das U.; Dimmock J.R.; Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-selective cytotoxicity and structure-activity relationships. Medicines (Basel)  2024,11(1),3","journal-title":"Medicines (Basel)"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0196-72","volume":"2","author":"Wahl A.F.","year":"1996","unstructured":"Wahl A.F.; Donaldson K.L.; Faircnild C.; Lee F.Y.F.; Foster S.A.; Demers G.W.; Galloway D.A.; Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis. Nat Med  1996,2(1),72-79","journal-title":"Nat Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.bbagen.2019.05.018","volume":"1863","author":"Assun&#xE7;&#xE3;o L.S.","year":"2019","unstructured":"Assun&#xE7;&#xE3;o L.S.; Kretzer I.F.; Sierra R.J.A.; de Mello Junior L.J.;; Silva A.H.; de Medeiros Oliveira E.; Ferreira M.; S&#xE1; M.M.; Creczynski-Pasa T.B.; Antitumor activity of methyl (Z)-2-(isothioureidomethyl)-2-pentenoate hydrobromide against leukemia cell lines via mitotic arrest and apoptotic pathways. Biochim Biophys Acta, Gen Subj  2019,1863(9),1332-1342","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3390\/ijms22094931","volume":"22","author":"Lica J.J.","year":"2021","unstructured":"Lica J.J.; Wiecz&#xF3;r M.; Grabe G.J.; Heldt M.; Jancz M.; Misiak M.; Gucwa K.; Brankiewicz W.; Maciejewska N.; Stupak A.; Bagi\u0144ski M.; Rolka K.; Hellmann A.; Sk\u0142adanowski A.; Effective Drug concentration and selectivity depends on fraction of primitive cells. Int J Mol Sci  2021,22(9),4931","journal-title":"Int J Mol Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/iovs.65.10.26","volume":"65","author":"van den Bosch Q.C.C.","year":"2024","unstructured":"van den Bosch Q.C.C.; Kili&#xE7; E.; Brosens E.; Uveal Melanoma Zebrafish Xenograft Models illustrate the mutation status-dependent effect of compound synergism or antagonism. Invest Ophthalmol Vis Sci  2024,65(10),26","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","volume":"116","author":"Sherr C.J.","year":"2004","unstructured":"Sherr C.J.; Principles of tumor suppression. Cell  2004,116(2),235-246","journal-title":"Cell"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tcb.2008.12.003","volume":"19","author":"Clarke P.R.","year":"2009","unstructured":"Clarke P.R.; Allan L.A.; Cell-cycle control in the face of damage \u2013 a matter of life or death. Trends Cell Biol  2009,19(3),89-98","journal-title":"Trends Cell Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2299046","DOI":"10.1080\/23723556.2023.2299046","volume":"11","author":"Alshwyeh H.A.","year":"2024","unstructured":"Alshwyeh H.A.; Al-Sheikh W.M.S.; Rasedee A.; Alnasser S.M.; Al-Qubaisi M.S.; Ibrahim W.N.; Mangifera indica L. kernel ethanol extract inhibits cell viability and proliferation with induction of cell cycle arrest and apoptosis in lung cancer cells. Mol Cell Oncol  2024,11(1),2299046","journal-title":"Mol Cell Oncol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4111\/icu.20240263","volume":"66","author":"Lee J.M.","year":"2025","unstructured":"Lee J.M.; Lee W.H.; Cho S.H.; Park J.W.; Kwon H.N.; Kim J.H.; Lee S.H.; Yoon J.H.; Park S.; Kim S.C.; DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment. Investig Clin Urol  2025,66(1),56-66","journal-title":"Investig Clin Urol"},{"key":"ref=56","first-page":"1325","volume":"69","author":"Koronkiewicz M.","year":"2012","unstructured":"Koronkiewicz M.; Kazimierczuk Z.; Szarpak K.; Chilmonczyk Z.; Proapoptotic effects of new pentabromobenzylisothiouronium salts in a human prostate adenocarcinoma cell line. Acta Pol Pharm  2012,69(6),1325-1333","journal-title":"Acta Pol Pharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e36503","DOI":"10.1371\/journal.pone.0036503","volume":"7","author":"Hoose S.A.","year":"2012","unstructured":"Hoose S.A.; Duran C.; Malik I.; Eslamfam S.; Shasserre S.C.; Downing S.S.; Hoover E.M.; Dowd K.E.; Smith R.; Polymenis M.; Systematic analysis of cell cycle effects of common drugs leads to the discovery of a suppressive interaction between gemfibrozil and fluoxetine. PLoS One  2012,7(5),e36503","journal-title":"PLoS One"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2109581","DOI":"10.1002\/adma.202109581","volume":"34","author":"Arjona M.I.","year":"2022","unstructured":"Arjona M.I.; Duch M.; Hern&#xE1;ndez-Pinto A.; V&#xE1;zquez P.; Agusil J.P.; G&#xF3;mez-Mart&#xED;nez R.; Redondo-Horcajo M.; Amirthalingam E.; P&#xE9;rez-Garc&#xED;a L.; Su&#xE1;rez T.; Plaza J.A.; Intracellular mechanical drugs induce cell\u2010cycle altering and cell death. Adv Mater  2022,34(17),2109581","journal-title":"Adv Mater"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41419-024-07265-6","volume":"15","author":"Hira A.","year":"2024","unstructured":"Hira A.; Zhang J.; Kadakia M.P.; TIP60 enhances cisplatin resistance via regulating \u0394Np63&#x3B1; acetylation in SCC. Cell Death Dis  2024,15(12),877","journal-title":"Cell Death Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"7220","DOI":"10.3390\/ijms25137220","volume":"25","author":"&#x15A;roda-Pomianek K.","year":"2024","unstructured":"&#x15A;roda-Pomianek K.; Barycka A.; Gle\u0144sk M.; Rajbhandari M.; Skonieczna M.; Palko-\u0141abuz A.; Weso\u0142owska O.; Pretreatment of melanoma cells with aqueous ethanol extract from Madhuca longifolia Bark strongly potentiates the activity of a low dose of dacarbazine. Int J Mol Sci  2024,25(13),7220","journal-title":"Int J Mol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1016\/S0021-9258(19)34062-1","volume":"265","author":"Andree H.A.","year":"1990","unstructured":"Andree H.A.; Reutelingsperger C.P.; Hauptmann R.; Hemker H.C.; Hermens W.T.; Willems G.M.; Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem  1990,265(9),4923-4928","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1388-1981(99)00110-9","volume":"1439","author":"Bevers E.M.","year":"1999","unstructured":"Bevers E.M.; Comfurius P.; Dekkers D.W.C.; Zwaal R.F.A.; Lipid translocation across the plasma membrane of mammalian cells. Biochim Biophys Acta Mol Cell Biol Lipids  1999,1439(3),317-330","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"Mizushima N.","year":"2007","unstructured":"Mizushima N.; Autophagy: Process and function. Genes Dev  2007,21(22),2861-2873","journal-title":"Genes Dev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"Levine B.","year":"2008","unstructured":"Levine B.; Kroemer G.; Autophagy in the pathogenesis of disease. Cell  2008,132(1),27-42","journal-title":"Cell"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-biophys-060414-034248","volume":"44","author":"Noda N.N.","year":"2015","unstructured":"Noda N.N.; Inagaki F.; Mechanisms of autophagy. Annu Rev Biophys  2015,44(1),101-122","journal-title":"Annu Rev Biophys"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41419-024-07228-x","volume":"15","author":"Luo Y.","year":"2024","unstructured":"Luo Y.; Liu R.; Zhang H.; Wang H.; Yin H.; Tian G.; Wang B.; Yan Y.; Ding Z.; Dai J.; Niu L.; Yuan G.; Pan Y.; Amantadine against glioma via ROS-mediated apoptosis and autophagy arrest. Cell Death Dis  2024,15(11),834","journal-title":"Cell Death Dis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article. Adv Drug Deliv Rev  2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H.Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem  2002,45(12),2615-2623","journal-title":"J Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.pharmthera.2023.108488","volume":"249","author":"Dong J.","year":"2023","unstructured":"Dong J.; Yuan L.; Hu C.; Cheng X.; Qin J.J.; Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review. Pharmacol Ther  2023,249,108488","journal-title":"Pharmacol Ther"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","volume":"94","author":"Hakkola J.","year":"2020","unstructured":"Hakkola J.; Hukkanen J.; Turpeinen M.; Pelkonen O.; Inhibition and induction of CYP enzymes in humans: An update. Arch Toxicol  2020,94(11),3671-3722","journal-title":"Arch Toxicol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biom14010099","volume":"14","author":"Lee J.","year":"2024","unstructured":"Lee J.; Beers J.L.; Geffert R.M.; Jackson K.D.; A review of CYP-mediated drug interactions: Mechanisms and in vitro drug-drug interaction assessment. Biomolecules  2024,14(1),99","journal-title":"Biomolecules"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206358941250413154017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/241477\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715206358941250413154017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T04:35:48Z","timestamp":1763094948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/241477\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":71,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715206358941250413154017","relation":{},"ISSN":["1871-5206"],"issn-type":[{"type":"print","value":"1871-5206"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}